Poor Prognosis After Second Locoregional Recurrences in the CALOR Trial

被引:0
作者
Irene L. Wapnir
Shari Gelber
Stewart J. Anderson
Eleftherios P. Mamounas
André Robidoux
Miguel Martín
Johan W. R. Nortier
Charles E. Geyer
Alexander H. G. Paterson
István Láng
Karen N. Price
Alan S. Coates
Richard D. Gelber
Priya Rastogi
Meredith M. Regan
Norman Wolmark
Stefan Aebi
机构
[1] Stanford University School of Medicine,NRG Oncology, Department of Surgery
[2] Dana-Farber Cancer Institute,IBCSG Statistical Center, Department of Biostatistics and Computational Biology
[3] and Frontier Science and Technology Research Foundation,NRG Oncology and Department of Biostatistics
[4] University of Pittsburgh Graduate School of Public Health,GEICAM, Instituto de Investigacion SanitariaGregorio Marañon
[5] NRG Oncology and University of Florida Health Cancer Center at Orlando Health,BOOG, Dutch Breast Cancer Trialists’ Group
[6] NRG Oncology and Centre Hospitalier de l’Universite de Montreal,IBCSG Statistical Center, Department of Biostatistics and Computational Biology
[7] Universidad Complutense,NRG Oncology
[8] Leids Universitair Medisch Centrum,IBCSG Statistical Center, Department of Biostatistics and Computational Biology
[9] NRG Oncology and Virginia Commonwealth University Massey Cancer Center,undefined
[10] NRG Oncology and Tom Baker Cancer Centre,undefined
[11] IBCSG and National Institute of Oncology,undefined
[12] IBCSG,undefined
[13] Bern,undefined
[14] Switzerland and University of Sydney,undefined
[15] Dana-Farber Cancer Institute,undefined
[16] Harvard TH Chan School of Public Health,undefined
[17] Harvard Medical School,undefined
[18] and Frontier Science and Technology Research Foundation,undefined
[19] University of Pittsburgh Cancer Institute,undefined
[20] Dana-Farber Cancer Institute,undefined
[21] Harvard Medical School,undefined
[22] NRG Oncology and the Allegheny Health Network Cancer Institute,undefined
[23] IBCSG,undefined
[24] Luzerner Kantonsspital,undefined
[25] Lucerne and University of Berne,undefined
[26] Switzerland and Swiss Group for Clinical Cancer Research (SAKK),undefined
来源
Annals of Surgical Oncology | 2017年 / 24卷
关键词
Primary Cancer; Distant Recurrence; Locoregional Recurrence; Hormone Receptor Status; Ipsilateral Breast Tumor Recurrence;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:398 / 406
页数:8
相关论文
共 84 条
[1]  
Halverson KJ(1992)Survival following locoregional recurrence of breast cancer: univariate and multivariate analysis Int J Radiat Oncol Biol Phys. 23 285-291
[2]  
Perez CA(1990)Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment Int J Radiat Oncol Biol Phys. 19 833-842
[3]  
Kuske RR(1991)Significance of ipsilateral breast tumour recurrence after lumpectomy Lancet. 338 327-331
[4]  
Fowble B(1995)Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events J Natl Cancer Inst. 87 19-27
[5]  
Solin LJ(2006)Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials J Clin Oncol. 24 2028-2037
[6]  
Schultz DJ(2006)Locoregional recurrence after mastectomy in high-risk breast cancer–risk and prognosis: an analysis of patients from the DBCG 82 b&c randomization trials Radiother Oncol. 79 147-155
[7]  
Fisher B(2009)Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer J Clin Oncol. 27 2466-2473
[8]  
Anderson S(2009)Unavoidable mastectomy for ipsilateral breast tumour recurrence after conservative surgery: patient outcome Ann Oncol. 20 1008-1012
[9]  
Fisher ER(2004)Repeat breast-conserving surgery for in-breast local breast carcinoma recurrence: the potential role of partial breast irradiation Cancer. 100 2269-2280
[10]  
Veronesi U(2002)Radiotherapy in the treatment of locoregional relapses of breast cancer Br J Radiol. 75 663-669